Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 31 citing articles:

Liquid biopsy: current technology and clinical applications
Mina Nikanjam, Shumei Kato, Razelle Kurzrock
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 439
Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy
Matin Chehelgerdi, Fereshteh Behdarvand Dehkordi, Mohammad Chehelgerdi, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 64
Fusion‐positive non‐small cell lung carcinoma: Biological principles, clinical practice, and diagnostic implications
Daniel Kazdal, Véronique Hofman, Petros Christopoulos, et al.
Genes Chromosomes and Cancer (2022) Vol. 61, Iss. 5, pp. 244-260
Closed Access | Times Cited: 45
Prognostic Biomarkers in Uveal Melanoma: The Status Quo, Recent Advances and Future Directions
Nuno Jorge Lamas, Arnaud Martel, Sacha Nahon‐Estève, et al.
Cancers (2021) Vol. 14, Iss. 1, pp. 96-96
Open Access | Times Cited: 41
Surface enhanced Raman spectroscopy for tumor nucleic acid: Towards cancer diagnosis and precision medicine
Lei Wu, Armando Dias, Lorena Diéguez
Biosensors and Bioelectronics (2022) Vol. 204, pp. 114075-114075
Closed Access | Times Cited: 33
Current and future applications of liquid biopsy in non-small-cell lung cancer—a narrative review
Bartłomiej Tomasik, Marcin Skrzypski, Michał Bieńkowski, et al.
Translational Lung Cancer Research (2023) Vol. 12, Iss. 3, pp. 594-614
Open Access | Times Cited: 18
Advancements of ALK inhibition of non-small cell lung cancer: a literature review
Victor Zia, Csongor György Lengyel, Carla Chizuru Tajima, et al.
Translational Lung Cancer Research (2023) Vol. 12, Iss. 7, pp. 1563-1574
Open Access | Times Cited: 15
Clinical Utility and Application of Liquid Biopsy Genotyping in Lung Cancer: A Comprehensive Review
Maria Concetta Nigro, Paola Valeria Marchese, Chiara Deiana, et al.
Lung Cancer Targets and Therapy (2023) Vol. Volume 14, pp. 11-25
Open Access | Times Cited: 13
Next-Generation Sequencing with Liquid Biopsies from Treatment-Naïve Non-Small Cell Lung Carcinoma Patients
Paul Hofman
Cancers (2021) Vol. 13, Iss. 9, pp. 2049-2049
Open Access | Times Cited: 28
The Landscape of ALK-Rearranged Non-Small Cell Lung Cancer: A Comprehensive Review of Clinicopathologic, Genomic Characteristics, and Therapeutic Perspectives
Valeria Cognigni, Federica Pecci, Alessio Lupi, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4765-4765
Open Access | Times Cited: 20
Clinically relevant fusion oncogenes: detection and practical implications
Maxim Sorokin, Elizaveta Rabushko, Julian M. Rozenberg, et al.
Therapeutic Advances in Medical Oncology (2022) Vol. 14
Open Access | Times Cited: 20
Potential utility of miRNAs for liquid biopsy in breast cancer
Xiangrong Liu, Dimitri Papukashvili, Zhixiang Wang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 17
Morphologic-Molecular Transformation of Oncogene Addicted Non-Small Cell Lung Cancer
Fiorella Calabrese, Federica Pezzuto, Francesca Lunardi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4164-4164
Open Access | Times Cited: 15
Current and emerging sequencing-based tools for precision cancer medicine
Anders Edsjö, David Gisselsson, Johan Staaf, et al.
Molecular Aspects of Medicine (2024) Vol. 96, pp. 101250-101250
Closed Access | Times Cited: 2
NGS‐based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment
Estela Sánchez‐Herrero, Roberto Serna‐Blasco, Vadym Ivanchuk, et al.
Molecular Oncology (2021) Vol. 15, Iss. 9, pp. 2363-2376
Open Access | Times Cited: 18
Cost‐effectiveness of precision diagnostic testing for precision medicine approaches against non‐small‐cell lung cancer: A systematic review
Raymond Henderson, Peter Keeling, Declan French, et al.
Molecular Oncology (2021) Vol. 15, Iss. 10, pp. 2672-2687
Open Access | Times Cited: 18
Actionability of on-target ALK Resistance Mutations in Patients With Non-Small Cell Lung Cancer: Local Experience and Review of the Literature
Bart Koopman, Harry J.M. Groen, Ed Schuuring, et al.
Clinical Lung Cancer (2021) Vol. 23, Iss. 2, pp. e104-e115
Open Access | Times Cited: 18
Daily Practice Assessment of KRAS Status in NSCLC Patients: A New Challenge for the Thoracic Pathologist Is Right around the Corner
Christophe Bontoux, Véronique Hofman, Patrick Brest, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1628-1628
Open Access | Times Cited: 12
Molecular Characterization and Therapeutic Approaches to Small Cell Lung Cancer: Imaging Implications
Hyesun Park, Shu-Chi Tseng, Lynette M. Sholl, et al.
Radiology (2022) Vol. 305, Iss. 3, pp. 512-525
Open Access | Times Cited: 12
The value of cell-free circulating tumour DNA profiling in advanced non-small cell lung cancer (NSCLC) management
Gabriela Fernandes, Natália Martins, José Carlos Machado, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 12
Circulating tumor DNA: current implementation issues and future challenges for clinical utility
Qilin Hu, Lüjun Chen, Kerui Li, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2023) Vol. 62, Iss. 11, pp. 2094-2110
Closed Access | Times Cited: 4
What Is New in Biomarker Testing at Diagnosis of Advanced Non-Squamous Non-Small Cell Lung Carcinoma? Implications for Cytology and Liquid Biopsy
Paul Hofman
Journal of Molecular Pathology (2021) Vol. 2, Iss. 2, pp. 147-172
Open Access | Times Cited: 11
Implementation of the clinical practice of liquid biopsies for thoracic oncology the experience of the RespirERA university hospital institute (Nice, France)
Paul Hofman
The Journal of Liquid Biopsy (2023) Vol. 1, pp. 100004-100004
Open Access | Times Cited: 2
STRN-ALKFusion in a Case of Malignant Peritoneal Mesothelioma: Mixed Response to Crizotinib, Mode of Resistance, and Brigatinib Sequential Therapy
Valeria Gerthofer, Alexander Scheiter, Florian Lüke, et al.
JCO Precision Oncology (2021), Iss. 5, pp. 1507-1513
Open Access | Times Cited: 5
Complications, Costs, and Health Care Resource Use with Tissue Biopsy Followed by Liquid Biopsy Versus Tissue Re-biopsy in Patients With Newly Diagnosed Metastatic Nonsmall-cell Lung Cancer
Anne Shah, Jon Apple, Saad Aslam, et al.
American Journal of Clinical Oncology (2024)
Open Access
Page 1 - Next Page

Scroll to top